Skip To The Main Content

Know Your Numbers for Analytical Similarity


Despite an increase in the approval of biosimilars in the United States, the development of biosimilar products continues to be challenging. Some questions about them have been partially resolved, such as the number of lots needed for the analytical similarity exercise, while others are still under discussion.

You need to Login to view the full article. Please Login. Not a Member? Join today!

PDA Members Save Substantially